Detects the JAK2 V617F mutation and mutations within exon 12 of the JAK2 gene.
Used to support the investigation of suspected myeloproliferative neoplasms, particularly polycythaemia vera, in people with abnormal blood counts. Results must be interpreted with the CBC, clinical findings and other haematology investigations.